https://doi.org/10.1007/s00401-023-02640-7
S
Sunjong Ji
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
148
Papers
543
Citations
11
h-index
11
i10-index
Sunjong Ji is an academic researcher. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Cancer, Hypoxia, and Metabolism & ATP Synthase and ATPases Research. The author has an h-index of 11, co-authored 126 publications.
ORCID: 0000-0002-6516-2380Papers by this author
worksClinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
2023 · Acta Neuropathologica · 31 citations
Proximogram—A multi-omics network-based framework to capture tissue heterogeneity integrating single-cell omics and spatial profiling
2024 · Computers in Biology and Medicine · 5 citations
https://doi.org/10.1016/j.compbiomed.2024.109082
Table S16 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27026252.v1
Table S2 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27026249
Supplementary Figures 1-15 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27026276.v1
Table S12 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27026264.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat